The overall objective is to enhance R&D on major societal challenges for improved healthcare by developing solutions for novel pharmaceutical products and
medical devices through new multicomponent drug systems. Our strategy will involve major stakeholders in the field including Universities, small and large
entreprises and final users (patients) as well as an economic development agency. Technology transfer and industrial competitiveness will be enhanced. Trainings
through technological develop. will create highly skilled scientists reducing the shortage of qualified staff in the field.